Boston Scientific (BSX) Income Statement

Click line-items for a historical chart and %

Net sales	2.11B
Cost of products sold	594M
Gross profit	1.51B
Selling, general and administrative expenses	772M
Research and development expenses	232M
Royalty expense	20M
Amortization expense	136M
Goodwill impairment charge
Intangible asset impairment charges	7M
Contingent consideration expense
Acquisition-related milestone
Restructuring charges	5M
Gain on divestiture
Operating expenses	1.16B
Operating income (loss)	348M
Interest expense	-58M
Other, net	-33M
Income (loss) before income taxes	257M
Income tax expense	29M
Net income (loss)	228M
Net income (loss) per common share - basic	0.17
Net income (loss) per common share - assuming dilution	0.17
Basic	1.36B
Assuming dilution	1.38B

Entities mentioned with BSX

View All Entities